After the first month, membership continues for $74 per month for the remainder of your 12-month plan
Review regulatory guidance and consult with your primary care provider if you have questions
Summary: Trulicity should not be combined with other GLP-1 receptor agonists or DPP-4 inhibitors, whilst insulin, sulphonylureas, and warfarin require careful monitoring and possible dose adjustments due to increased hypoglycaemia or altered anticoagulation risk
Some people experience noticeable drowsiness while taking Mounjaro, and you should speak with your healthcare provider about persistent or severe sleepiness
Where serum B12 results are borderline or do not fit the clinical picture, further tests such as active B12 (holotranscobalamin), methylmalonic acid, or homocysteine may be helpful
Previous studies have linked ENOC to endometriosis, suggesting that reduced GLP-1 levels in peritoneal fluid may contribute to endometriosis development 75,76,77